N. Arvind Dasari, MD (Gastrointestinal Oncology)Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard
Houston, TX 77030
Tel: 1-877-671-8612 (appointments, new patients)
Tel: 1-877-671-8612 (appointments, current and returning patients)
Since joining MD Anderson in 2011, Dr. Dasari’s clinical focus has been on neuroendocrine malignancies and he currently serves as co-Chair of the MD Anderson multidisciplinary neuroendocrine tumor board. Dr. Dasari’s research interests include clinical, translational and outcomes work in gastrointestinal cancers with a particular emphasis on neuroendocrine tumors. He serves as the principal investigator of several clinical trials and research projects on neuroendocrine tumors. He is currently a member of the NCI Task Force for Neuroendocrine Tumors, is co-Chair of the SWOG Neuroendocrine Subcommittee and also chairs the NANETS’ Continuing Education Committee.
Dr. Dasari is a co-author of numerous articles including the seminal publication “Trends in the Incidence, Prevalence, and Survival Outcomes in Patients with Neuroendocrine Tumors in the United States,” published in JAMA Oncology; articles on carcinoid syndrome and carcinoid heart disease; and articles on treatments and clinical trials for NETs.